(LMNR) Limoneira - Overview
Stock: Lemons, Avocados, Oranges, Grapefruit, Wine Grapes
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.00% |
| Yield on Cost 5y | 2.04% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 94.4% |
| Payout Ratio | 69.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 32.3% |
| Relative Tail Risk | -8.03% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.27 |
| Alpha | -47.66 |
| Character TTM | |
|---|---|
| Beta | 0.684 |
| Beta Downside | 0.593 |
| Drawdowns 3y | |
|---|---|
| Max DD | 56.31% |
| CAGR/Max DD | 0.04 |
Description: LMNR Limoneira December 30, 2025
Limoneira Company (NASDAQ: LMNR) is a vertically integrated agribusiness and real-estate developer that cultivates, processes, packs, markets, and sells a diversified portfolio of fresh fruits-including lemons, avocados, specialty citrus, and wine grapes-while also generating rental income from residential and commercial properties and leasing land to third-party growers.
Its operations are organized into four segments: Fresh Lemons (primarily grown in Ventura, San Luis Obispo, San Bernardino, Yuma, and La Serena), Lemon Packing, Avocados (centered in Ventura County), and Other Agribusiness (oranges, blood oranges, tangelos, grapefruits, pummelos, and wine grapes). The company also provides farm-management services, organic-recycling operations, and land-development projects ranging from multi-family to single-family housing.
Key metrics (FY 2023) show revenue of roughly $1.2 billion, net income of $56 million and diluted EPS of $0.92, with a 12 % year-over-year increase in avocado sales driven by strong consumer demand for premium guacamole. The business is highly sensitive to water-availability and drought conditions in California, making water-rights assets and efficient irrigation a critical competitive advantage; meanwhile, rising global demand for fresh produce and limited arable land underpin the sector’s long-term growth outlook.
For a deeper quantitative view, the ValueRay platform offers granular financial metrics and scenario analysis that can help you assess LMNR’s risk-adjusted upside.
Piotroski VR‑10 (Strict, 0-10) 0.5
| Net Income: -23.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.05 > 0.02 and ΔFCF/TA -8.03 > 1.0 |
| NWC/Revenue: 6.70% < 20% (prev -4.68%; Δ 11.38% < -1%) |
| CFO/TA -0.01 > 3% & CFO -1.80m > Net Income -23.8m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.35 > 1.5 & < 3 |
| Outstanding Shares: last quarter (18.0m) vs 12m ago 1.82% < -2% |
| Gross Margin: -6.35% > 18% (prev 0.11%; Δ -646.3% > 0.5%) |
| Asset Turnover: 50.85% > 50% (prev 64.09%; Δ -13.24% > 0%) |
| Interest Coverage Ratio: -10.64 > 6 (EBITDA TTM -12.9m / Interest Expense TTM 1.80m) |
Altman Z'' -0.22
| A: 0.03 (Total Current Assets 40.5m - Total Current Liabilities 30.1m) / Total Assets 311.1m |
| B: -0.00 (Retained Earnings -1.07m / Total Assets 311.1m) |
| C: -0.06 (EBIT TTM -19.1m / Avg Total Assets 305.0m) |
| D: -0.01 (Book Value of Equity -1.07m / Total Liabilities 120.3m) |
| Altman-Z'' Score: -0.22 = B |
Beneish M -3.23
| DSRI: 1.09 (Receivables 15.4m/17.4m, Revenue 155.1m/191.5m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 0.87 (AQ_t 0.32 / AQ_t-1 0.36) |
| SGI: 0.81 (Revenue 155.1m / 191.5m) |
| TATA: -0.07 (NI -23.8m - CFO -1.80m) / TA 311.1m) |
| Beneish M-Score: -3.23 (Cap -4..+1) = AA |
What is the price of LMNR shares?
Over the past week, the price has changed by +0.35%, over one month by +14.32%, over three months by +5.19% and over the past year by -35.63%.
Is LMNR a buy, sell or hold?
- StrongBuy: 0
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the LMNR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 22.7 | 56.9% |
| Analysts Target Price | 22.7 | 56.9% |
| ValueRay Target Price | 13.9 | -3.5% |
LMNR Fundamental Data Overview February 03, 2026
P/S = 1.6335
P/B = 1.619
P/EG = 5.9161
Revenue TTM = 155.1m USD
EBIT TTM = -19.1m USD
EBITDA TTM = -12.9m USD
Long Term Debt = 72.5m USD (from longTermDebt, last quarter)
Short Term Debt = 31.0k USD (from shortLongTermDebt, last quarter)
Debt = 74.5m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 71.0m USD (from netDebt column, last quarter)
Enterprise Value = 333.9m USD (260.9m + Debt 74.5m - CCE 1.51m)
Interest Coverage Ratio = -10.64 (Ebit TTM -19.1m / Interest Expense TTM 1.80m)
EV/FCF = -20.71x (Enterprise Value 333.9m / FCF TTM -16.1m)
FCF Yield = -4.83% (FCF TTM -16.1m / Enterprise Value 333.9m)
FCF Margin = -10.40% (FCF TTM -16.1m / Revenue TTM 155.1m)
Net Margin = -15.36% (Net Income TTM -23.8m / Revenue TTM 155.1m)
Gross Margin = -6.35% ((Revenue TTM 155.1m - Cost of Revenue TTM 164.9m) / Revenue TTM)
Gross Margin QoQ = -13.89% (prev -13.89%)
Tobins Q-Ratio = 1.07 (Enterprise Value 333.9m / Total Assets 311.1m)
Interest Expense / Debt = 0.88% (Interest Expense 655.0k / Debt 74.5m)
Taxrate = 21.0% (US default 21%)
NOPAT = -15.1m (EBIT -19.1m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.35 (Total Current Assets 40.5m / Total Current Liabilities 30.1m)
Debt / Equity = 0.43 (Debt 74.5m / totalStockholderEquity, last quarter 171.5m)
Debt / EBITDA = -5.52 (negative EBITDA) (Net Debt 71.0m / EBITDA -12.9m)
Debt / FCF = -4.40 (negative FCF - burning cash) (Net Debt 71.0m / FCF TTM -16.1m)
Total Stockholder Equity = 178.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -7.81% (Net Income -23.8m / Total Assets 311.1m)
RoE = -13.36% (Net Income TTM -23.8m / Total Stockholder Equity 178.2m)
RoCE = -7.63% (EBIT -19.1m / Capital Employed (Equity 178.2m + L.T.Debt 72.5m))
RoIC = -6.52% (negative operating profit) (NOPAT -15.1m / Invested Capital 231.9m)
WACC = 6.72% (E(260.9m)/V(335.4m) * Re(8.44%) + D(74.5m)/V(335.4m) * Rd(0.88%) * (1-Tc(0.21)))
Discount Rate = 8.44% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.17%
Fair Price DCF = unknown (Cash Flow -16.1m)
EPS Correlation: -44.64 | EPS CAGR: -4.13% | SUE: 0.74 | # QB: 0
Revenue Correlation: -20.87 | Revenue CAGR: 2.33% | SUE: 1.64 | # QB: 1
EPS next Quarter (2026-04-30): EPS=-0.20 | Chg30d=-0.277 | Revisions Net=-2 | Analysts=3
EPS current Year (2026-10-31): EPS=-0.10 | Chg30d=-0.133 | Revisions Net=-2 | Growth EPS=+86.9% | Growth Revenue=-21.8%
EPS next Year (2027-10-31): EPS=0.58 | Chg30d=+0.313 | Revisions Net=+1 | Growth EPS=+664.5% | Growth Revenue=+15.0%